Yildirim, S.; Dogan, A.; Akdag, G.; Cavdar, E.; Kinikoglu, O.; Oksuz, S.; Yildiz, H.S.; Kucukoz Uzun, A.; Isik, D.; Surmeli, H.;
et al. A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 2024, 16, 2512.
https://doi.org/10.3390/cancers16142512
AMA Style
Yildirim S, Dogan A, Akdag G, Cavdar E, Kinikoglu O, Oksuz S, Yildiz HS, Kucukoz Uzun A, Isik D, Surmeli H,
et al. A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers. 2024; 16(14):2512.
https://doi.org/10.3390/cancers16142512
Chicago/Turabian Style
Yildirim, Sedat, Akif Dogan, Goncagul Akdag, Eyyup Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Isik, Heves Surmeli,
and et al. 2024. "A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients" Cancers 16, no. 14: 2512.
https://doi.org/10.3390/cancers16142512
APA Style
Yildirim, S., Dogan, A., Akdag, G., Cavdar, E., Kinikoglu, O., Oksuz, S., Yildiz, H. S., Kucukoz Uzun, A., Isik, D., Surmeli, H., Basoglu, T., Sever, O. N., Odabas, H., Yildirim, M. E., & Turan, N.
(2024). A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers, 16(14), 2512.
https://doi.org/10.3390/cancers16142512
